Apellis Pharmaceuticals Patents – Insights & Stats (Updated 2024)
Apellis Pharmaceuticals has a total of 371 patents globally, out of which 144 have been granted. Of these 371 patents, more than 71% patents are active. The United States of America is where Apellis Pharmaceuticals has filed the maximum number of patents, followed by Hong Kong (S.A.R.) and Europe (EPO).
